Dingkang Medical's Eight-Year Journey: What It Got Right to Secure Hundreds of Millions in Funding and Achieve Profitability

DK Medtech FinancingNumber100 million yuan.

The joys and sorrows of human beings are not interconnected. The "capital winter" seen in the eyes of countless people has been glaringly illuminated by the "hundreds of millions" flame of DK Medtech.

Even without full understanding, one thing can be confidently predicted: DK Medtech and its team must have done something right, and its leader, Weng Yulin, must have made the right decisions for the company’s growth.

Therefore,ColdWinter Just IsThe Cold Winter of Others,The StrongThere will always be a turning point,Splendid Flowers in Full Bloom。

1, Track

In hindsight, some remarks seem like Monday morning quarterbacking.

Avoid the overcrowded and fiercely competitive major tracks, where the competition is bound to be cutthroat; instead, seek out the scarcities in smaller niches and strive to be among the top tier—this is not an irrational choice.

DK MedtechThe Starting PointIt is a balloon.

Balloon, in China, is already dominated by a group of big players, experts, and talented individuals. Breaking through this competition is extremely difficult.DK Medtech Balloon TechnologyFocus onAt that time, it was still silent.AVF (ArteriovenousFistula) Track,At the same time, through the development of drug technology and scoring technology, DK Medtech has carried out a multi-product line layout (high, medium, and low) in AVF.

In this way, during the era when neurointervention and structural cardiology were attracting massive investments and making a big splash, DK Medtech embarked on its journey from an inconspicuous corner.

It was a capital-crazed era that, even in hindsight, feels utterly insane. But,Isolation of Temptation, is the effort of how many people and teamsThe psychological barrier that cannot be touched.After all, at that time, there were billions of financing in the social circle,The industry may not surpass technology and clinical aspects, but it will certainly highlight the depth of capital.

How difficult it is to persist correctly and wholeheartedly!

2. Product

High Pressure + Scoring + Drug Coating, DK Medtech has created a "three-in-one" super balloon with this technology, along with other gradient balloons, forming its own product lineup.

BuildInnovation and Scarcity, FormingProduct Gradient(In response to the payment needs of different patients), DK Medtech has formed its own track lineup through the focus on the AVF sector and the extension of balloon products in the泛血管 field.

Which products are high-volume, which are high-margin; which are outsourced, which are sold directly; everything is clear and transparent.

This is a progressive matrix that extends from the product to the track, and from the track to sales.

It is also one of the successful methodologies of DK Medtech.

3, Sales

Nowadays, if you ask, most capital and enterprises would say: Commercializing medical devices is harder than scaling the heavens.Hematopoietic ProfitabilityIs the king.

The DK Medtech team originated from the technical end,But those familiar with DK Medtech's developmentAs we all know, asCompany Leader, ProductBeyond Methodology,The sales end is also almost entirelyWeng YuLinRun through.

ChinaRun Hospital, Director Pao, Running Agent, talk about the product, this seemingly light description, but anyone who has personally been on the front lines knows the difficulty and hardship involved.

Weng Yulin's sales methodology is actually quite simple: people should take on difficult tasks, and founders even more so.The hardest part is sales, so I must step up myself.; Moreover, we cannot rely on the sales logic of foreign enterprises from those years—it was the platform’s halo effect. As a domestic brand, we must be diligent and patient.

A wide range of products have been made,But it really can be likeWeng YuLin is sellingThere are very few founders who charge into the front lines.

Products are scarce, people are scarce, and value is thus generated in this scarcity.

4, Weng Yulin

Investing, in the end, is all about investing in people—this is the golden rule of the investment world.

Due toThe biggest variable is people,Those who can create infinite value are also people.

Weng Yulin started from the stent era at JW Medical (Biosensors), and then embarked on the entrepreneurial path with technological expertise.Like countlessEntrepreneurshipThe story is the same, onceApproachNo money to pay salaries,It has also been criticized by others and struggled during the pandemic.

ButRu WengyuLinInner StrengthLogic：EntrepreneurshipNine deaths, one life,Difficulty is Normal；These pressures are all part of the job.Matters.Thus maintaining clarity,Stay Positive。

This is the wisdom of an entrepreneur, as well as his idealism.The life of an idealist may be tragic,But never pitiful！That is to always embrace the futureInfinite longing and pursuit,Continuously exploring in value.

The tide of entrepreneurship is upon us, but the change in momentum lies in the hands of people. Amid the sweeping trend of medical devices, there are players navigating these turbulent waters.

Complementing Each Other, Forming a Strong Presence and Building People.

5, DK Medtech

In 2023, DK Medtech turned a profit, marking just over seven years since the company's establishment.

Enterprises must be profitable.Regardless of valuation, this is the underlying value that DK Medtech has always adhered to.Increase Revenue, Reduce CostsThe simplest profit formula has become the focus of their attention.

Increased revenue comes from products and innovation, while cost reduction lies in the efficiency of the team. Running through it all is their rapid error correction and quick adjustments.Thereby formingThe Positive Cycle of Enterprise Development.

Especially nowadays, new enterprises almost entirely rely on financing to stay afloat, and even after their products have been certified for five or six years, they are still operating at a loss.

Looking back, the once-prominent fields of neurointervention and structural cardiology still haven't found the path to profitability, and are even struggling with deficits or on the brink of closure.

It is unpredictable how DK Medtech will fare after the ongoing centralized procurement; it is unpredictable how DK Medtech will fare amidst the deepening internal competition within the industry; or it could be said, there is no answer as to what shape DK Medtech will ultimately grow into.

But you will definitely have high expectations for DK Medtech today, hoping that it continues on its path to profitability and even envisions its future road to an IPO. This is because it is positive for the industry and beneficial to society.

This is enough for the company.

6. Reference

Therefore, DK Medtech's current brilliance is worth learning from and referencing in the industry.

Perhaps there could be countless words describing this company, and countless concerns evaluating it. However, DK Medtech, standing on its 8-year journey, must have done something right that over 90% of the current industry players have failed to achieve.

Is it a product? A track? A person? Or......?

Thousands of people, thousands of answers; learning for practical use is enough.

Tail

The father plays a game with his child. The father picks up a world map, tears it into small pieces, and says to the child:

"If you put it together, I'll give you a reward."

The father thought it would take at least half a day, but to his surprise, the child finished in less than ten minutes. He was astonished to see that the entire map had been restored to its original state.

"How did you put it together so quickly?"

"It's very simple. There is a picture of a person on the back of this map. I think, if the person is assembled correctly, then when flipped over, the map should also be correct."

The child continued:

"When the person is right, the world is right."

Blessings to the companies in China to withstand the cold winter, and look forward to more companies becoming profitable. Also, looking forward to "the right DK Medtech" creating its own "right world."